Texas Department of State Health Services Home


   

Find Services | News & Information | Rules & Regulations | Business Information 
 (Buscar)

Forms & Instructions: Research, PHI, & Close

Prior to Submitting an Application

The first step in submitting an application is to contact the appropriate DSHS Program Contact. (Alphabetical list of Programs and Contacts)

Once you have gotten in touch with the Program Contact, discuss what you need and determine the best way to present your request. Complete the latest version of the application, which can be downloaded from our website. Attach any additional materials. Make the appropriate number of copies. Sign the original, and send the submission to the Program Contact for his/her signature. The Program Contact will forward the submission to the IRB Office after signing the application.

New Submission Forms and Instructions Renewal Submission Forms and Instructions Amendments Study Closure

New Submission
Forms
Application form WORD / PDF [61kb]
Request for Exemption from Review of Research form WORD / PDF [78kb]
(Note: Federal regulations do not allow research involving prisoners, fetuses, pregnant women, or human in vitro fertilization to be exempted.)
Request for Expedited Review of Research form WORD / PDF [74kb]
Protocol Checklist WORD / PDF [72kb]
Submission Checklist WORD / PDF [44kb]
   
Instructions
Investigator must submit through the Program Contact:
 

One original and 14 copies (copies double-sided, no staples) of the following:

    Application.  The latest version of the DSHS Application, typed, and signed by both the principal investigator/requestor and the program contact (the program contact will sign the original application before forwarding the submission to the IRB Office).

    Project Description.  Provide a clear statement of the work to be undertaken and must include:
      A) Summary/synopsis of the research project. This is a critical part of the submission because it introduces the reviewers to the study to get a quick understanding of just what is being proposed.  The summary of study objectives should be written as if you were trying to give an overview of your research to someone who is not a scientist or medical professional.  Include a brief description of the subject area(s) to be investigated.  It is not necessary to include a complete description of the study design in this portion of the submission; rather, give a general sense of the strategy and/or techniques involved.

      B) Research Plan:
      1-Introduction/Background – should contain the history of the disease or condition and current treatment or control measures.  References to pertinent studies and the rationale for the proposed modalities should also be presented.

      2-Objectives/Specific Aims – Summarize the purpose of the study/data request and state any public health benefits.  State study hypothesis or hypotheses.

      C) Subject Selection:
      1-Study Population – this section should describe the population under study, the potential sources and the number and sample size methodology used to determine the proposed sample.  If a data request include years of data requested.

      2-Eligibility Criteria – inclusion criteria, such as: sites, stage of disease/histology, age (lower and upper limits should be stated), performance status, laboratory values, and other evaluations as applicable, etc.  Explain the rationale for the use of special classes of subjects such as fetuses, pregnant women, women of childbearing potential, children, institutionalized mentally disabled, prisoners, or others, especially those whose ability to give voluntary informed consent may be in question.

      3-Ineligibility Criteria– exclusion criteria, such as: prior treatment, prior other diseases, infection, hematologic, and other values that preclude entry into study.

      4-Recruitment/Registration – this section should describe how potential subjects will be identified and contacted.  This should include the specifics of who will recruit subjects, when, where and how and the information to provide to the subject.  Advertisements, flyers, and any other materials that will be used to recruit subjects must be reviewed and approved before their use.  If a data request has a follow-back component to individuals or their next of kin, describe in detail here.

      D) Protocol Details:
      1-Research Design and Methods – This section should describe the type of research to be conducted (e.g. experimental, quasi-experimental, case study, evaluation, outcome, etc.) and the methods used to conduct the research such as intervention therapy (e.g. surgery, drugs, radiation, exposure (e.g. media campaign, curriculum, best practice, etc).

      2-Subject Assessment – this section should contain the requirements for each assessment to be conducted.  The studies to be done and the follow-up times should also be detailed in either outline or graphic format.

      3-Data – this section should contain a list of all data items [for the release of DSHS data, specific information on the use of individual data fields may be required as defined by DSHS program area – submit a completed and approved data request form from the DSHS program, if available], including forms, and the specified timetable for collection.  Specify the type and format of the data requested (i.e. copies of certificates or electronic files, and years needed).  Specify if names or other identifying information is needed.  Include a discussion of confidentiality safeguards including the specific steps you will take to a) provide privacy during interviews, b) keep forms/data secure, c) keep data confidential, d) prevent release or publication of identifying data, and e) retain and ultimately dispose of records.  Specifically describe all health information and/or hospital discharge data that the project will be using and/or requesting (e.g., personal identification information; billing records; medical history; physical findings from exams; lab, pathology and radiology results; results of MRIs, X-Rays, blood test and similar tests; PHI previously collected for research purposes; answers to questionnaires/interviews, etc.).  If you will use the entire medical file, then you must mention this fact specifically.  Include descriptions of potential uses of the final products that may be created using the data.  [For hospital discharge data requests, download, complete, and attach the THCIC data element form.  For personal data requests, download, complete and attach the appropriate personal data, data element form(s).]

      4-Statistical Design & Analysis – this section should include a discussion of the end point(s), the difference expected, and the analytical methods to be employed to detect the difference.

      5-Informed Consent Document – this section should contain all forms to be used, each form should be clearly identified and dated.

      6-Risks/Benefits – this section should include procedures for protecting against or minimizing risks, the potential benefits to be gained by the subjects, and the benefits that may accrue to society in general because of the planned work.  Describe any potential risks--physical, psychological, social, legal, or other--and assess their likelihood and seriousness.  Describe alternative methods, if any, that were considered and why they will not be used.  Where relevant, describe arrangements for providing medical treatment if needed.

      7-Student Investigator/Requestor – if you are a student, indicate the relationship of the proposal to your program of work and identify your supervising/sponsor faculty member.  The student’s committee must approve thesis and dissertation proposals before approval by the IRB.

      E) Appendices. This section should include documentation and material, such as: questionnaires, surveys and other assessment tools; brochures, media flyers; certificates of human subject training; letters of support from data sources and DSHS Program Contacts/approval from study sites and/or other IRBs.  Translated materials are not required for review until approval of the English version(s) is obtained.

      F) Funding. If the study will be funded by a federal agency, please include a copy of the full grant proposal or a detailed summary.

      An investigator using a consent form and other instruments in a language other than English will need to submit the translated version along with the credentials and qualifications of the translator(s).  Non-English version(s) will be requested after approval the English version.
Submission Deadline
  Applications must be received in the DSHS IRB #1 Office before the first working day of the month to be scheduled for full board review in that month.  Applications received on or after the first working day of the month, that cannot be exempted or examined using an expedited review procedure, will be scheduled for a full board review in the following month.  Send your complete submission, original and copies, to the program contact listed on the first page of the application.  The program contact will need time to review and sign the application and forward the submission to the IRB Office before the 1st working day of the month.

An exemption or an expedited review can be requested.

Top of page

Renewal Submission
Forms
Application form WORD / PDF [61kb]
Request for Expedited Review of Research form WORD / PDF [74kb]
Renewal Submission Checklist WORD / PDF [27kb]
   
Instructions
Investigator must submit through the Program Contact
  One original and 14 copies (copies double-sided, no staples) of the following:  the latest version of the application, typed, and signed by both the principal investigator and the program contact, and a clean copy of the currently approved consent document.  All revisions must be clearly identified and described on the updated materials with clean copies of any instruments that need approval.
Submission must:
  Briefly, 1) summarize the study protocol [1-2 paragraphs].  2) Discuss the reason for continuing the study.  3) Include a Synopsis of changes since last review (Summary of any relevant recent literature, interim findings, scientific developments, and amendments or modifications to the research since the last review).  4) List the number and the gender, ethnic/racial, and age breakdown (if appropriate) of subjects recruited to date.  5) Describe any unforeseen or adverse events and response since the last review.  6) List the number of withdrawals since the last review and the reason(s) for the withdrawals.  7) List the number of complaints concerning the research, received since the last review and summarize the complaints.  8)  Include any relevant multi-center trial reports and any other relevant information especially about risks associated with the research.  9) Include a copy of the current consent document and any newly proposed consent document.  10) Identify specific sites/agencies used and their IRB approval status.  11) Include copies of the current approval documents from any other IRBs who reviewed this study.
Submission Deadline
  Applications must be received in the before the first working day of the month to be scheduled for full board review in that month.  Applications received on or after the first working day of the month, that cannot be exempted or examined using an expedited review procedure, will be scheduled for a full board review in the following month.  Send your complete submission, original and copies, to the program contact listed on the first page of the application.  The program contact will need time to review and sign the application and forward the submission before the 1st working day of the month.

An expedited review can be requested.

Top of page

Amendments
Forms
Application form WORD / PDF [61kb]
Amendment Request form WORD / PDF [27kb]

Top of page

Study Closure
Forms
Final Report upon Termination of Project form WORD / PDF [44kb]

Top of page

Last Updated June 1, 2007

Contact Us | Compact with Texans | Homeland Security | Internet Policy | Site Map | Statewide Search | Texas Online